A CHALLENGING DIAGNOSIS AND TREATMENT OF PRIMARY BLADDER ADENOCARCINOMA: LITERATURE REVIEW

Abstract

Bladder adenocarcinoma is a histological variant that only represents 0.5-2% of cases. The bladder cancer is expected to affect one in 27 men and one in 89 women over the course of their lifetime, with a lifetime risk of approximately 2.2% in the general population in the united states. The bladder can develop primary or secondary adenocarcinomas, with secondary adenocarcinomas being more frequent than primary adenocarcinomas. The primary bladder adenocarcinoma falls into two broad categories: urachal and non-urachal. Patients with non- urachal primary bladder adenocarcinoma appear to have a worse prognosis than those with urachal adenocarcinoma. It is essential to know better about the diagnosis, current treatment and prognosis of the primary bladder adenocarcinoma. Here we describe the article review regarding the primary bladder adenocarcinoma